| Literature DB >> 27706046 |
Alexander Tallner1, René Streber2, Christian Hentschke3, Marc Morgott4, Wolfgang Geidl5, Mathias Mäurer6, Klaus Pfeifer7.
Abstract
Physical exercise is effective in improving functional outcomes in persons with multiple sclerosis (pwMS). We evaluated the feasibility and effectiveness of internet-based exercise training (e-training) for pwMS on health-related quality of life (HrQoL). Secondary outcomes were muscle strength, aerobic capacity, lung function, physical activity, and fatigue. This is a randomised, controlled trial with a wait-list control group. Data were collected at baseline, after three and six months, and analysed using a hybrid linear model. One-hundred twenty-six pwMS participated in the home-based aerobic (1×/week) and strength training (2×/week) intervention that was supervised and documented via an internet-platform. The intervention group received e-training for six months, and the control group received e-training after a three months waiting period. Significant differences between the groups were only observed for muscle strength (knee flexion (effect size ES = 0.3, p = 0.003), knee extension (ES = 0.24, p = 0.015)), peak expiratory flow (ES = 0.2, p = 0.039), and sports activity (ES = 0.33, p = 0.001) after three months. E-training had no effect on HrQoL but did on muscle strength, lung function, and physical activity. It is a promising and feasible approach to facilitate large-scale, yet individual, training support.Entities:
Keywords: aerobic training; exercise; fatigue; health-related quality of life; internet; lung function; multiple sclerosis; physical activity; resistance training; telerehabilitation
Mesh:
Year: 2016 PMID: 27706046 PMCID: PMC5085700 DOI: 10.3390/ijms17101667
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Flowchart of the study (study centres: Erl—Erlangen, BadM—Bad Mergentheim).
Baseline characteristics of the study participants by group (mean (SD) or n (%)).
| Title | Intervention Group ( | Control Group ( | Total Sample ( | Difference Between Groups a |
|---|---|---|---|---|
| Number | ||||
| Female | 44 (75%) | 50 (75%) | 94 (75%) | NA |
| Male | 15 (25%) | 17 (25%) | 32 (25%) | NA |
| Type of Multiple Sclerosis | ||||
| relapsing-remitting | 52 (88%) | 57 (85%) | 109 (87%) | NA |
| secondary-progressive | 7 (12%) | 10 (15%) | 17 (13%) | NA |
| Age (Range 16–76) | 40.9 (10.4) | 40.7 (9.5) | 40.8 (9.9) | |
| Duration of disease | 9.8 (9.2) | 9.2 (7.2) | 9.5 (8.2) | |
| EDSS | 2.8 (0.8) | 2.7 (0.8) | 2.7 (0.8) |
a—Based on t-test; EDSS—Expanded Disability Status Scale; NA—Not applicable.
Figure 2Compliance over the study period.
Primary and secondary outcomes by group (mean (SD)) at baseline, three-month, and six-month assessment.
| Outcome | Intervention Group | Control Group | ||||
|---|---|---|---|---|---|---|
| Baseline | Three-Month | Six-Month | Baseline | Three-Month | Six-Month | |
| HRQoL | 1.84 (0.42) | 1.85 (0.49) | 1.87 (0.49) | 1.79 (0.4) | 1.83 (0.42) | 1.78 (0.43) |
| Fatigue | 21.3 (12.9) | 19.05 (14.4) | 23.87 (15.0) | 23.5 (16.3) | 21.93 (15.3) | 20.56 (14.9) |
| Aerobic fitness (VO2peak) | 25.3 (6.1) | 25.66 (5.39) | 25.32 (6.63) | 25.2 (6.5) | 24.91 (6.29) | 25.51 (6.68) |
| Forced vital capacity (L) | 4.0 (0.9) | 4.18 (0.86) | 4.17 (0.77) | 4.18 (0.96) | 4.17 (0.99) | 4.22 (1.00) |
| Peak expiratory flow (L/sec) | 6.0 (1.53) | 6.41 (1.43) | 6.54 (1.56) | 6.78 (1.69) | 6.72 (1.59) | 6.94 (1.58) |
| Knee extension (Nm) | 287 (100) | 302.81 (93) | 311.1 (100) | 298 (118) | 292.98 (113) | 292.07 (111) |
| Knee flexion (Nm) | 156 (50) | 177.71 (59) | 181.45 (52) | 171 (65) | 175.3 (63) | 179.05 (62) |
| Trunk extension (Nm) | 169 (62) | 169.88 (59) | 181.66 (58) | 168 (67) | 169.26 (72) | 173.24 (69) |
| Trunk flexion (Nm) | 86 (32) | 91.41 (32) | 95.17 (31) | 85 (36) | 88.32 (38) | 91.07 (39) |
| Sport score | 2.3 (2.47) | 3.24 (2.73) | 3.36 (2.33) | 2.1 (2.43) | 1.9 (2.39) | 2.86 (2.89) |
HRQoL—Health-related quality of life; L—litres; Nm—Newton metre; VO2peak—Peak oxygen consumption in O2 mL/(kg·min).
Time effects and between group effects at three and six months after baseline assessment.
| Outcome | Intervention Group (Time Effect) | Control Group (Time Effect) | Between Group Difference (Group × Time) | |||
|---|---|---|---|---|---|---|
| Mean Change [95% CI] | Mean Change [95% CI] | Difference of Mean Changes a [95% CI] | ||||
| HRQoL | ||||||
| Three-month | 0.02 [−0.06, 0.11] | 0.08, | 0.03 [−0.04, 0.11] | 0.11, | −0.01 [−0.12, 0.10] | −0.01, |
| Six-month | 0.04 [−0.06, 0.13] | 0.13, | −0.05 [−0.14, 0.03] | −0.18, | ||
| Fatigue | ||||||
| Three-month | −2.06 [−5.74, 1.62] | −0.16, | −1.81 [−5.11, 1.49] | −0.14, | −0.25 [−5.19, 4.69] | −0.01, |
| Six-month | 5.3 [1.15, 9.46] | 0.42, | −1.3 [−5.03, 2.43] | −0.1, | ||
| Aerobic fitness (VO2peak) | ||||||
| Three-month | 0.13 [−0.83, 1.08] | 0.04, | −0.33 [−1.19, 0.54] | −0.1, | 0.45 [−0.84, 1.74] | 0.07, |
| Six-month | −0.34 [−1.46, 0.78] | −0.11, | 0.71 [−0.28, 1.71] | 0.23, | ||
| Forced vital capacity (L) | ||||||
| Three-month | −0.03 [−0.12, 0.05] | −0.11, | −0.02 [−0.1, 0.06] | −0.06, | −0.01 [−0.13, 0.1] | −0.02, |
| Six-month | −0.01 [−0.11, 0.09] | −0.03, | 0.05 [−0.04, 0.14] | 0.19, | ||
| Peak expiratory flow (L/sec) | ||||||
| Three-month | 0.36 [0.07, 0.65] | 0.35, | −0.06 [−0.33, 0.21] | −0.06, | 0.42 [0.03, 0.82] | 0.2, |
| Six-month | 0.12 [−0.22, 0.46] | 0.12, | 0.23 [-0.08, 0.53] | 0.23, | ||
| Knee extension (Nm) | ||||||
| Three-month | 20.52 [7.56, 33.48] | 0.46, | −1.39 [−12.91, 10.13] | −0.03, | 21.91 [4.57, 39.24] | 0.24, |
| Six-month | 5.11 [−9.96, 20.18] | 0.11, | 0.04 [−13.29, 13.38] | 0.0, | ||
| Knee flexion (Nm) | ||||||
| Three-month | 19.61 [12.03, 27.19] | 0.76, | 3.62 [−3.11, 10.35] | 0.14, | 16 [5.86, 26.13] | 0.3, |
| Six-month | 2.34 [−6.39, 11.07] | 0.09, | 4.17 [−3.55, 11.89] | 0.16, | ||
| Trunk extension (Nm) | ||||||
| Three-month | −1.11 [−9.53, 7.31] | −0.04, | 0.02 [−7.54, 7.57] | 0, | −1.13 [−12.44, 10.18] | −0.02, |
| Six-month | 10.21 [0.56, 19.86] | 0.36, | 4.46 [−4.1, 13.02] | 0.16, | ||
| Trunk flexion (Nm) | ||||||
| Three-month | 6.29 [2.65, 9.93] | 0.5, | 3.95 [0.69, 7.21] | 0.31, | 2.34 [−2.55, 7.22] | 0.09, |
| Six-month | 3.2 [−1.01, 7.41] | 0.26, | 2.93 [-0.8, 6.66] | 0.24, | ||
| Sport score | ||||||
| Three-month | 0.91 [0.44, 1.37] | 0.55, | −0.19 [−0.61, 0.24] | −0.11, | 1.09 [0.46, 1.73] | 0.33, |
| Six-month | 0.12 [−0.41, 0.66] | 0.08, | 0.96 [0.47, 1.45] | 0.59, | ||
a—higher values display positive changes in favor of the intervention group, except for HrQoL and Fatigue scales; ES—standardized effect size; HRQoL—Health-related quality of life; L—liters; Nm—newton metre; VO2peak—peak oxygen consumption in O2 mL/(kg·min).